XENT News and Press, Intersect ENT Inc. From 06/27/19

Jeryl Hilleman to Step Down as CFO as Part of Planned Transition in 2020 Intersect ENT ® , Inc. (Nasdaq:XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced the appointment of Thomas (“Tom”) A. West as Pre...

Pooled analysis of the RESOLVE and RESOLVE II Studies Provides Level 1a Clinical Evidence Intersect ENT ® , Inc. (NASDAQ: XENT), a company dedicated to transforming care for patients with ear, nose and throat conditions, today announced publication of a pooled analysis of the RES...

NEW YORK, May 20, 2019 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, reminds investors in Intersect ENT, Inc. ("Intersect" or the "Company") (NASDAQ: XENT) of the July 15, 2019 deadline to seek the role of lead plaintiff in a federal securities class ...

Glancy Prongay & Murray LLP (“GPM”) announces an investigation on behalf of Intersect ENT, Inc. (“Intersect ENT” or the “Company”) (NASDAQ: XENT ) investors concerning the Company and its officers’ possible violations of federal securit...

Gainers:  Bridgeline Digital (NASDAQ: BLIN ) +30% . Cohu (NASDAQ: COHU ) +27% . ATA (NASDAQ: ATAI ) +25% . ARCA biopharma (NASDAQ: ABIO ) +24% . SolarEdge Technologies (NASDAQ: SEDG ) +23% . Summit Wireless Technologies (NASDAQ: WISA ) +22% . Itron (NASDAQ: ITRI ) +21% . Sunwor...

Catalyst Pharmaceuticals (NASDAQ: CPRX )  -39%  after FDA OKs Firdapse competitor. More news on: Catalyst Pharmaceuticals, Inc., Intersect ENT, Inc., TherapeuticsMD, Inc., Stocks on the move, Read more ...

Welltower (NYSE: WELL ) upgraded to Outperform with an $86 (13% upside) price target at BMO. Yesterday, it announced new management hires and added the Chairman role to CEO Thomas DeRosa. More news on: Welltower Inc., Teva Pharmaceutical Industries Limited, Intersect ENT, Inc., Healthc...

Intersect ENT, Inc. (XENT) Q1 2019 Results Earnings Conference Call May 06, 2019, 04:30 PM ET Company Participants Jeryl Hilleman - CFO Kieran Gallahue - Edwards Lifesciences Corporation, Independent Director Lisa Earnhardt - CEO, President Conference Call Participants Na S...

Intersect ENT (NASDAQ: XENT ) announces that CEO Lisa Earnhardt will resign on June 5 to accept another position while maintaining her board membership. More news on: Intersect ENT, Inc., Healthcare stocks news, Stocks on the move, Read more ...

Gainers: SEDG   +18.5% . AVID   +10.2% . APT   +9.3% . AIG   +6.4% . LCI   +5.7% . More news on: SolarEdge Technologies, Inc., Avid Technology, Inc., Alpha Pro Tech, Ltd., Stocks on the move, Read more ...